Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

Comments

Loading...

Reckitt Benckiser Group Stock News

RBGPFOTCQX

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$81.00

-0.60-0.74%

Last update: Dec 16, 10:19 AM

News

Latest Reckitt Benckiser Group Stock News | OTC:RBGPF | Benzinga

Get the latest news on Reckitt Benckiser Group stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Reckitt Benckiser Group performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, November 08, 2024

FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
Vandana Singh

Wednesday, September 18, 2024

Consumer Giant Reckitt Seeks Help From Investment Banks To Evaluate Options For Homecare Brands, Baby Formula
Vandana Singh

Monday, July 08, 2024

Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits
Vandana Singh

Friday, March 15, 2024

What's Going On With Abbott Laboratories Stock On Friday?
Vandana Singh

Thursday, February 29, 2024

Durex Owner Reckitt Benckiser Taps Into China's Livestreaming Trend To Sell Condoms Online
Benzinga Neuro

Tuesday, September 12, 2023

FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
Vandana Singh

Wednesday, May 24, 2023

Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process
Vandana Singh

Friday, December 02, 2022

Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report
Anusuya Lahiri

Thursday, September 01, 2022

Dettol Maker Reckitt Benckiser's CEO Steps Down
Shivani Kumaresan

Thursday, August 11, 2022

Baby Formula Startup Seeks To Compete Abbott With 15% Market Share: Report
Vandana Singh

Wednesday, July 27, 2022

Reckitt Lifts Annual Forecast On Higher Prices, Baby Formula Shortage
Vandana Singh

Wednesday, May 25, 2022

More Companies Join Race To Ease US Baby Formula Supply Crunch
Vandana Singh

Friday, May 20, 2022

Danone Scales Up Baby Formula Shipments To US To Combat Shortage: Reuters
Vandana Singh

Friday, April 29, 2022

Morning Brief: Top Financial Stories Dominating on Friday, April 29
Akanksha Bakshi
Reckitt Benckiser Hikes Prices To Compensate For Falling Demand: FT
Shivani Kumaresan

Thursday, October 26, 2017

Wall Street's M&A Chatter From October 25: Sprint-T-Mobile, Trade Desk, Pfizer, Dynegy
Benzinga

Monday, July 17, 2017

Wall Street's M&A Chatter From July 14-16: Dominion Diamond, Unilever-Hormel-Reckitt, H&E Equipment-Neff, Mobileye-Intel
Benzinga

Thursday, May 01, 2014

Benzinga's M&A Chatter for Thursday May 1, 2014
Benzinga

Wednesday, April 30, 2014

Reckitt Benckiser Confirms it is No Longer in...
Benzinga

Monday, April 28, 2014

Benzinga's M&A Chatter for Monday April 28, 2014
Benzinga
Reckitt Benckiser Confirms Talks With Merck R...
Benzinga
Benzinga's Weekend M&A Chatter
Benzinga

Saturday, April 26, 2014

Reuters Reports Merck in Talks to Sell Consum...
Benzinga

Friday, November 22, 2013

Reuters Reports Reckitt Benckiser Hires Morgan Stanley to Advise on Options for Pharma Unit
Benzinga

Wednesday, September 11, 2013

Reckitt Benckiser CEO Rakesh Kapoor Says Company has Ability to do Large M&A -Reuters
Benzinga

Thursday, November 22, 2012

Benzinga's M&A Chatter for Wednesday November 21, 2012
Benzinga

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved